Skip to main content
. 2024 Aug 21;16(16):2903. doi: 10.3390/cancers16162903

Table 1.

Summary of characteristics a of the patients included in the study.

[ALL] Cancer Control p-Value N b
N = 380 N = 115 N = 265
Age 64.0 [54.0; 71.0] 68.0 [62.5; 74.0] 61.0 [51.0; 70.0] <0.001 380
Gender: <0.001 380
F 153 (40.3%) 28 (24.3%) 125 (47.2%)
M 227 (59.7%) 87 (75.7%) 140 (52.8%)
Lymphocytes, ×103/µL 1.73 [1.24; 2.33] 1.47 [1.07; 2.09] 1.80 [1.33; 2.38] 0.002 368
Neutrophils, ×103/µL 5.51 [4.11; 7.92] 7.92 [5.65; 10.4] 4.86 [3.85; 6.61] <0.001 369
Platelets, ×103/µL 270 [216; 336] 336 [269; 402] 252 [203; 308] <0.001 368
Hemoglobin, g/dL 13.4 [12.2; 14.5] 12.8 [11.2; 14.0] 13.5 [12.6; 14.8] <0.001 360
Smoking, packs/year 20.0 [0.00; 40.0] 40.0 [20.0; 50.0] 10.0 [0.00; 30.0] <0.001 337
COPD: <0.001 378
n 194 (51.3%) 31 (27.4%) 163 (61.5%)
y 184 (48.7%) 82 (72.6%) 102 (38.5%)
Cardiovascular pathologies 0.1 2212
n 58 (27.4%) 31 (27.7%) 27 (27.0%)
y 154 (72.6%) 81 (72.3%) 73 (73.0%)
Diabetes mellitus 0.217 2211
n 165 (78.2%) 91 (82.0%) 74 (74.0%)
y 46 (21.8%) 20 (18.0%) 26 (26.0%)
Renal pathologies 0.1 2209
n 194 (92.8%) 101 (92.7%) 93 (93.0%)
y 15 (7.18%) 8 (7.34%) 7 (7.00%)
BMI, kg/m2 27.0 [23.4; 30.7] 24.6 [21.4; 27.3] 29.3 [26.0; 33.1] <0.001 144
NLR 3.00 [2.00; 5.30] 5.30 [3.15; 8.35] 2.60 [1.80; 4.30] <0.001 368
PLR 153 [109; 218] 217 [150; 342] 136 [105; 192] <0.001 367

a Values are presented as numbers (percentages) for categorical variables and medians [interquartile range] for numerical variables. b Number of observations for a given variable. COPD = chronic obstructive pulmonary disease.